RE:RE:status of thingsThanks RC. As i understand the Immusafe JV structure, Test 1 is 50-50 rev split and Test 2 would be 80-20 in favor of PMN due to use of PMN reagents.
Regarding US market, I suspect they have been talking w/ FDA given some of the statements on the covidimmunitypassport website about US samples being sent for processing to a specific approved lab in WA state.
But perhaps there is some reciprocity agreement between FDA and HC that they are leveraging as well.
Regarding competition, I think PMN is in a pretty good spot still, given those recent application templates posted by FDA, as well as the recent FDA announcement you shared.
At the end of the day, if we enter a JV with someone, we share the success as well as the blame for any misteps.
I am hopeful that the curent regulatory climate will be amenable to speedy approvals. The world needs answers on these questions asap.